Information about Johnson & Johnson’s transparency data

The Medicines New Zealand and New Zealand Medical Association (NZMA) Joint Transparency Initiative (effective 1 January 2021) aims to promote public confidence in the biopharmaceutical industry through increasing transparency around the interactions between Healthcare Professionals and companies from the innovative medicines sector.

This means Johnson & Johnson may publish information when we provide payments or transfers of value to Healthcare Professionals. Reportable payments and transfers of value are:

• payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an advisory board or as a consultant, and
• airfares, accommodation and/or conference registration fees to attend medical education or as part of speaking or consulting services.

Disclosure requirements also apply to transfers of value made to New Zealand Healthcare Organisations such as hospitals or medical practices.

In accordance with the Medicines New Zealand Transparency Guidelines and New Zealand Privacy Legislation, Johnson & Johnson publishes a yearly report (1 January to 31 December) which identifies Healthcare Professionals by name. Reports will be accessible on the company website by 30 June for a minimum of three years from publication. Links are available below.